A Budget Impact Analysis of Fidaxomicin Versus Vancomycin and Metronidazole for the Treatment of Clostridium Difficile
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1426
https://www.valueinhealthjournal.com/article/S1098-3015(17)31760-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1268
First Page :
A632
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31760-6&doi=10.1016/j.jval.2017.08.1426